Asthma associated with the use of cocaine, heroin, and marijuana: A review of the evidence

Self, Timothy H.; Shah, Samarth; March, Katherine; Sands, Christopher W.

doi:10.1080/02770903.2016.1259420

Cited by 36 publications

(26 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Prior studies using synthetic THC analogues [9][10][11] have not incorporated the whole cannabis plant and, therefore, cannot evaluate other substances, such as terpenes and flavonoids, that may enhance or provide additional therapeutic properties. 49 At the same time, the numerous potential risks of cannabis in this population, including drug-drug interactions, 17,50 infections, 16,51-54 sinopulmonary side effects, 18,[54][55][56] neuropsychiatric sequelae, 19,57 and unintended overdoses/poisonings, [58][59][60][61] argue for rigorous safety studies. Currently, however, the US government continues to classify cannabis as a schedule I drug, and this restricts federal funding for safety studies and those assessing its therapeutic use in this population.…”

Section: Discussionmentioning

confidence: 99%

Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use

Pergam

Woodfield

Lee

et al. 2017

Cancer

230

188

View full text Add to dashboard Cite

BACKGROUNDCannabis is purported to alleviate symptoms related to cancer treatment, although the patterns of use among cancer patients are not well known. This study was designed to determine the prevalence and methods of use among cancer patients, the perceived benefits, and the sources of information in a state with legalized cannabis.METHODSA cross‐sectional, anonymous survey of adult cancer patients was performed at a National Cancer Institute–designated cancer center in Washington State. Random urine samples for tetrahydrocannabinol provided survey validation.RESULTSNine hundred twenty‐six of 2737 eligible patients (34%) completed the survey, and the median age was 58 years (interquartile range [IQR], 46‐66 years). Most had a strong interest in learning about cannabis during treatment (6 on a 1‐10 scale; IQR, 3‐10) and wanted information from cancer providers (677 of 911 [74%]). Previous use was common (607 of 926 [66%]); 24% (222 of 926) used cannabis in the last year, and 21% (192 of 926) used cannabis in the last month. Random urine samples found similar percentages of users who reported weekly use (27 of 193 [14%] vs 164 of 926 [18%]). Active users inhaled (153 of 220 [70%]) or consumed edibles (154 of 220 [70%]); 89 (40%) used both modalities. Cannabis was used primarily for physical (165 of 219 [75%]) and neuropsychiatric symptoms (139 of 219 [63%]). Legalization significantly increased the likelihood of use in more than half of the respondents.CONCLUSIONSThis study of cancer patients in a state with legalized cannabis found high rates of active use across broad subgroups, and legalization was reported to be important in patients' decision to use. Cancer patients desire but are not receiving information about cannabis use during their treatment from oncology providers. Cancer 2017;123:4488‐97. © 2017 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

show abstract

Section: Discussionmentioning

confidence: 99%

Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use

Pergam

Woodfield

Lee

et al. 2017

Cancer

230

188

View full text Add to dashboard Cite

show abstract

“…Finalmente, en cuanto a otras sustancias, la evidencia demuestra que la inhalación de cocaína o heroína se asocia con un incremento en los síntomas del asma y con una reducción de la función pulmonar. Además, se ha publicado que el consumo de crack, el esnifar cocaína o heroína o fumar heroína, incrementan el riesgo de visitas a urgencias, así como a sufrir hospitalizaciones a causa del asma (Self, Shah, March y Sands, 2017). En otra revisión se expone que la proporción de consumidores de heroína es mayor en los pacientes asmáticos y que la prevalencia de asma y de hiperreactividad bronquial es mayor entre los consumidores de heroína.…”

Section: Sustancias Tóxicas Inhaladasunclassified

Documento de consenso sobre asma y tabaquismo del Foro Autonómico de Asma de la SEPAR

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Asthme et polyconsommation de SPA L'asthme fait partie des complications pulmonaires associées à usage de tabac et/ou de cannabis (voie inhalée) ainsi que de cocaïne ou d'héroïne (voie IV ou inhalée) [85,86]. Karila et al [87] ont montré que les consommateurs de SPA fument plus, ont une dépendance tabagique plus importante et sont plus vulnérables aux effets du tabac que les sujets de la population générale.…”

Section: Difficultés Diagnostiquesunclassified

Asthme et usage d’héroïne

et al. 2017

View full text Add to dashboard Cite

show abstract

Asthma associated with the use of cocaine, heroin, and marijuana: A review of the evidence

Abstract: Use of cocaine and heroin in patients with asthma should be avoided. Pending further studies, it would be prudent for patients with asthma to avoid smoking marijuana. Clinicians need to be vigilant regarding use of these drugs in their patients with hyperreactive airway disease.

Cited by 36 publications

References 47 publications

Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use

Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use

Documento de consenso sobre asma y tabaquismo del Foro Autonómico de Asma de la SEPAR

Asthme et usage d’héroïne

Contact Info

Product

Resources

About